| Identification | Back Directory | [Name]
Deltarasin (hydrochloride) | [CAS]
1440898-82-7 | [Synonyms]
Deltarasin (hydrochloride)
Deltarasin trihydrochloride
Deltarasin hydrochloride (1:?)
2-[4-[(2S)-2-(2-Phenyl-1H-benzimidazol-1-yl)-2-(4-piperidinyl)ethoxy]phenyl]-1-(phenylmethyl)-1H-benzimidazole trihydrochloride | [Molecular Formula]
C40H40Cl3N5O | [MDL Number]
MFCD28252145 | [MOL File]
1440898-82-7.mol | [Molecular Weight]
713.138 |
| Hazard Information | Back Directory | [Uses]
Deltarasin (cas# 1440898-82-7) is a useful research chemical.Deltarasin was used as a reagent in studying small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling. | [Biological Activity]
deltarasin hydrochloride is a selective inhibitor of kras-pdeδ interaction with ic50 value of 41±12 nm [1].kras, also known as v-ki-ras2 kirsten rat sarcoma viral oncogene homolog, is a protein and works as a molecular on/off switch whose mutant is an essential step in the development of many cancers. pdeδ (prenyl binding protein) controls the spatial organization of k-ras, which enhances ras diffusion in the cytosol. inhibition of the ras-pdeδ interaction by small molecules impairs ras localization and signaling has becoming a promising strategy to treat cancers in clinic [1, 2].deltarasin hydrochloride is a potent kras-pdeδ interaction inhibitor. when tested with human pancreatic ductal adenocarcinoma cells deltarasin hydrochloride showed inhibition on kras-pdeδ interaction to inhibit oncogenic ras signaling and suppressed cell proliferation by binding to pdeδ with kd value of 41 nm [1].in nude mice model with panc-tu-i xenograft, administration of deltarasin hydrochloride (10, 15 mg/kg) impaired cells growth and decreased tumor volume after 9 days in a dose-dependent manner [1]. | [storage]
Store at -20°C | [References]
[1]. zimmermann, g., et al., small molecule inhibition of the kras-pdedelta interaction impairs oncogenic kras signalling. nature, 2013. 497(7451): p. 638-42.
[2]. the kras-pdedelta interaction is a therapeutic target. cancer discov, 2013. 3(7): p. of20. |
|
| Company Name: |
Musechem
|
| Tel: |
+1-800-259-7612 |
| Website: |
www.musechem.com |
| Company Name: |
Axon Medchem BV
|
| Tel: |
+31-50-3118007 |
| Website: |
www.axonmedchem.com |
|